Schonfeld Strategic Advisors’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-59,964	Closed	-$605K	–	3417
2022 Q3	$605K	Sell	59,964 -40,000	-40%	-$403K	0.01%	1610
2022 Q2	$1M	Sell	99,964 -50,033	-33%	-$503K	0.01%	1025
2022 Q1	$1.52M	Sell	149,997 -46,269	-24%	-$468K	0.01%	833
2021 Q4	$1.98M	Buy	+196,266	New	+$1.99M	0.02%	710

Other funds holding LVACU

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Schonfeld Strategic Advisors's LVACU Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q4 2022, closing a stake of 59,964 shares — an estimated $605K sold.

Schonfeld Strategic Advisors first reported a position in LVACU in Q4 2021 and held it in 4 quarters. The position peaked at $1.98M in Q4 2021. 6 funds tracked by Wall St. Rank hold LVACU as of Q4 2022.

Schonfeld Strategic Advisors reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 59,964 LAVA Medtech Acquisition Corp. Unit shares in Q4 2022, an estimated $605K.
Schonfeld Strategic Advisors first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
Schonfeld Strategic Advisors's LAVA Medtech Acquisition Corp. Unit position peaked at $1.98M in Q4 2021.
6 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.